US Broker Ratings

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy with 43.5% Revenue Growth

Alignment Healthcare, Inc. (ALHC), a prominent player in the healthcare plans industry, has garnered significant attention from investors, thanks to its impressive revenue growth and a suite of favorable analyst..

Liquidia Corporation (LQDA) Investor Outlook: A Biotech Stock Riding High on 1,121.70% Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) has captured the spotlight with its remarkable revenue growth of 1,121.70%, positioning itself as a notable player in the biotechnology sector. Based in Morrisville, North Carolina,..

Envista Holdings Corporation (NVST) Investor Outlook: Navigating a 11.50% Revenue Growth in the Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) stands out in the healthcare sector as a significant player in the medical instruments and supplies industry. With a market capitalization of $4 billion, this..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Potential 44.88% Upside Fuels Investor Interest

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands out in the biotechnology landscape with a compelling precision medicine approach to oncology. With a market capitalization of $3.02 billion, this healthcare sector innovator..

Travere Therapeutics (TVTX) Stock Analysis: Exploring a 40% Upside in Rare Disease Biotechnology

Travere Therapeutics, Inc. (TVTX) is making waves in the biotechnology sector, particularly in the niche of rare kidney and metabolic diseases. With a market cap of $2.68 billion and a..

ImmunityBio, Inc. (IBRX) Stock Analysis: Potential Upside of 90% for This Biotech Innovator

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its impressive potential upside of 90%, according to average analyst target prices. As a biotechnology firm focused on harnessing..

Addus HomeCare Corporation (ADUS) Investor Outlook: Assessing the 27.75% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a stalwart in the healthcare sector, has caught the attention of investors with its promising potential upside of 27.75%. This figure is not just a..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 21.56% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking exposure to the healthcare sector. With a market..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 59% Potential Upside in Biotech Innovation

Denali Therapeutics Inc. (DNLI), a trailblazer in the biotechnology sector, is capturing investor attention with its robust pipeline aimed at tackling neurodegenerative and lysosomal storage diseases. Headquartered in South San..

Belite Bio, Inc (BLTE) Stock Analysis: A 14.79% Upside Beckons in the Biotech Sector

Belite Bio, Inc (NASDAQ: BLTE) presents a compelling opportunity in the healthcare sector, particularly for investors with an appetite for biotechnology ventures. Founded in 2016 and based in San Diego,..

Certara, Inc. (CERT) Stock Analysis: Unpacking a 22% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT) stands at the crossroads of healthcare innovation and investment opportunity. As a leader in the health information services industry, Certara offers a suite of technology-enabled services..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Its Impressive Revenue Growth and Financial Health

National HealthCare Corporation (NHC), operating in the healthcare sector with a focus on medical care facilities, has garnered attention for its robust revenue growth and financial health. With a market..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 80% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX) is a prominent player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $875.57 million, GoodRx offers a..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 17% Potential Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical innovator focused on developing peptide therapeutics for complex blood disorders and inflammatory diseases, stands out in the biotechnology sector with a market capitalization..

NovoCure Limited (NVCR) Stock Analysis: An Investor’s Look at 81.53% Potential Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling opportunity. As a specialist in medical devices, NovoCure focuses on innovative solutions for treating..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Standout with 26% Upside Potential

For investors keen on the healthcare sector, PACS Group, Inc. (PACS) presents a compelling opportunity. With a focus on skilled nursing and assisted living facilities, PACS operates a portfolio that..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Strong Buy Ratings Highlight Potential Upside

For investors seeking opportunities in the healthcare sector, Brookdale Senior Living Inc. (NYSE: BKD) presents an intriguing case. With a market capitalization of $3.04 billion, this Brentwood, Tennessee-based company is..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 27% Upside Potential Amidst Strong Revenue Growth

For investors eyeing opportunities within the biotechnology sector, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents an intriguing prospect. With a market capitalization of $1.68 billion, this U.S.-based biopharmaceutical company is pushing..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Look at the 46.90% Potential Upside and Cutting-Edge Genetic Medicine Advancements

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of biotechnology innovation with its ambitious focus on precision genetic medicines. Headquartered in Cambridge, Massachusetts, this company is making waves in..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 64% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a promising name in the biotechnology industry, drawing significant attention from investors due to its innovative approach and strategic partnerships. Headquartered in Watertown, Massachusetts,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds